Literature DB >> 10712946

Lineage commitment in lymphopoiesis.

M Busslinger1, S L Nutt, A G Rolink.   

Abstract

The mechanisms controlling the commitment of hematopoietic progenitor cells to the lymphoid lineages are still mostly unknown. Recent findings indicate that the earliest phase of B cell development may proceed in two steps. At the onset of B-lymphopoiesis, the transcription factors E2A and EBF coordinately activate the B-cell-specific gene expression program. Subsequently, Pax5 appears to repress the promiscuous transcription of lineage-inappropriate genes and thus commits progenitor cells to the B-lymphoid pathway by suppressing alternative cell fates. B-lineage commitment by Pax5 seems to occur in a stochastic manner in the bone marrow, as indicated by the random activation of only one of the two Pax5 alleles in early pro-B cells. In contrast, loss- and gain-of-function analyses have implicated the Notch1 receptor in the specification of the T cell fate, which may thus be controlled by instructive signals in the thymus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712946     DOI: 10.1016/s0952-7915(99)00065-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  17 in total

1.  Identification of a germ-line pro-B cell subset that distinguishes the fetal/neonatal from the adult B cell development pathway.

Authors:  Li-Sheng Lu; James Tung; Nicole Baumgarth; Ometa Herman; Michael Gleimer; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

2.  Unsuspected role of the brain morphogenetic gene Otx1 in hematopoiesis.

Authors:  Elena Levantini; Alessandra Giorgetti; Francesco Cerisoli; Elisabetta Traggiai; Alessandra Guidi; Richard Martin; Dario Acampora; Peter D Aplan; Gordon Keller; Antonio Simeone; Norman N Iscove; Trang Hoang; Maria Cristina Magli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-21       Impact factor: 11.205

3.  Identifying genetic loci and spleen gene coexpression networks underlying immunophenotypes in BXD recombinant inbred mice.

Authors:  Rachel M Lynch; Sudhir Naswa; Gary L Rogers; Stephen A Kania; Suchita Das; Elissa J Chesler; Arnold M Saxton; Michael A Langston; Brynn H Voy
Journal:  Physiol Genomics       Date:  2010-02-23       Impact factor: 3.107

4.  Alcohol affects the late differentiation of progenitor B cells.

Authors:  Hao Wang; Huijuan Zhou; Simon Mahler; Robert Chervenak; Michael Wolcott
Journal:  Alcohol Alcohol       Date:  2010-11-22       Impact factor: 2.826

5.  The GOD of hematopoietic stem cells: a clonal diversity model of the stem cell compartment.

Authors:  C E Muller-Sieburg; H B Sieburg
Journal:  Cell Cycle       Date:  2006-02-15       Impact factor: 4.534

Review 6.  Escape From ALL-CARTaz: Leukemia Immunoediting in the Age of Chimeric Antigen Receptors.

Authors:  Sisi Zheng; Mukta Asnani; Andrei Thomas-Tikhonenko
Journal:  Cancer J       Date:  2019 May/Jun       Impact factor: 3.360

7.  Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.

Authors:  Duonan Yu; David Allman; Michael H Goldschmidt; Michael L Atchison; John G Monroe; Andrei Thomas-Tikhonenko
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

8.  Gradient of E2A activity in B-cell development.

Authors:  Sabine Herblot; Peter D Aplan; Trang Hoang
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

9.  A complex network of regulatory elements in Ikaros and their activity during hemo-lymphopoiesis.

Authors:  Christoph Kaufmann; Toshimi Yoshida; Elizabeth A Perotti; Esther Landhuis; Paul Wu; Katia Georgopoulos
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

10.  Inhibition of p300/CBP by early B-cell factor.

Authors:  Fang Zhao; Ruth McCarrick-Walmsley; Peter Akerblad; Mikael Sigvardsson; Tom Kadesch
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.